Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ·Healthcare·Biotechnology
$24.78
+1.41%
Mkt Cap $1.54B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 12, 2026 | $12.09M | $19.97M | +65.14% | -$1.97 | -$1.85 | +6.09% | — | — |
| Q4 2025 Oct 30, 2025 | $11.70M | $12.88M | +10.09% | -$1.93 | -$1.78 | +7.77% | — | — |
| Q3 2025 Jul 31, 2025 | $10.28M | $12.46M | +21.16% | -$1.74 | -$1.93 | -10.92% | — | — |
| Q2 2025 May 1, 2025 | $9.99M | $8.73M | -12.62% | -$1.80 | -$1.55 | +13.89% | — | — |
| Q1 2025 Feb 13, 2025 | $9.35M | $10.73M | +14.79% | -$1.69 | -$1.74 | -2.96% | — | — |
| Q4 2024 Oct 31, 2024 | $9.27M | $8.96M | -3.30% | $16.69 | $4.20 | -74.84% | — | — |
| Q3 2024 Aug 1, 2024 | $9.31M | $8.62M | -7.47% | -$1.58 | -$1.69 | -6.96% | — | — |
| Q2 2024 May 2, 2024 | $9.75M | $8.19M | -16.01% | -$1.64 | -$1.45 | +11.59% | — | — |
| Q1 2024 Feb 15, 2024 | $7.92M | $7.10M | -10.34% | -$1.64 | -$1.72 | -4.88% | — | — |
| Q4 2023 Nov 2, 2023 | $7.53M | $7.40M | -1.69% | -$1.69 | -$1.64 | +2.96% | — | — |
| Q3 2023 Aug 3, 2023 | $6.46M | $6.71M | +3.90% | -$1.60 | -$1.51 | +5.63% | — | — |
| Q2 2023 May 4, 2023 | $5.23M | $5.61M | +7.25% | -$1.72 | -$1.47 | +14.53% | — | — |
| Q1 2023 Feb 23, 2023 | $4.54M | $4.31M | -4.97% | -$1.59 | $0.67 | +142.14% | — | — |
| Q4 2022 Nov 3, 2022 | $5.27M | $3.52M | -33.26% | -$1.75 | -$1.49 | +14.86% | — | — |
| Q3 2022 Aug 4, 2022 | $2.91M | $5.58M | +92.12% | -$1.78 | -$1.68 | +5.62% | — | — |
| Q2 2022 May 5, 2022 | $864.18K | $832.00K | -3.72% | -$1.85 | -$1.74 | +5.95% | — | — |
| Q1 2022 Feb 24, 2022 | $2.94M | $41 | -100.00% | -$1.71 | -$1.81 | -5.85% | — | — |
| Q4 2021 Nov 3, 2021 | $2.60M | — | — | -$1.61 | -$1.48 | +8.07% | — | — |
| Q3 2021 Jul 29, 2021 | — | $37.35M | — | -$1.39 | -$1.36 | +2.16% | — | — |
| Q2 2021 Apr 29, 2021 | $43.53M | $41.41M | -4.87% | -$1.23 | -$1.31 | -6.50% | — | — |